CD44 and cancer: Some specific markers are over-expressed on the membranes of cancer cells, such as integrin αvβ3, CD44 and receptors of transferrin, folic acid and galactose, the ligands of which could be grafted onto the surface of gas-releasing nanomedicines to recognize cancer cells.